메뉴 건너뛰기




Volumn 98, Issue 9, 2003, Pages 493-498

Treatment of Thrombosis with Low-Molecular-Weight Heparin. Comparison of Body Weight-Adjusted and Fixed Dosage;Thrombosetherapie mit Niedermolekularem Heparin: Vergleich von Körpergewichtsadjustierter mit Fixer Dosierung

Author keywords

Deep vein thrombosis; Hemorrhage; Heparin; Low molecular weight heparin; Mortality; Recurrent thromboembolism

Indexed keywords

CERTOPARIN; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

EID: 0345688766     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-003-1290-9     Document Type: Review
Times cited : (2)

References (21)
  • 1
    • 0035283104 scopus 로고    scopus 로고
    • Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis
    • Breddin HK, Hach-Wunderle V, Nakov R, et al. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001;344:626-31.
    • (2001) N Engl J Med , vol.344 , pp. 626-631
    • Breddin, H.K.1    Hach-Wunderle, V.2    Nakov, R.3
  • 2
    • 0034707685 scopus 로고    scopus 로고
    • A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: Examining some unanswered questions regarding location of treatment, product type, and dosing frequency
    • Dolovich LR, Ginsberg JS, Douketis JD, et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 2000;160:181-8.
    • (2000) Arch Intern Med , vol.160 , pp. 181-188
    • Dolovich, L.R.1    Ginsberg, J.S.2    Douketis, J.D.3
  • 3
    • 0025151664 scopus 로고
    • Randomized controlled study of heparin and low molecular weight heparin for prevention of deep vein thrombosis in medical patients
    • Harenberg J, Kallenbach B, Martin U, et al. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep vein thrombosis in medical patients. Thromb Res 1990;59:639-50.
    • (1990) Thromb Res , vol.59 , pp. 639-650
    • Harenberg, J.1    Kallenbach, B.2    Martin, U.3
  • 4
    • 0034020857 scopus 로고    scopus 로고
    • Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis
    • EASTERN Investigators
    • Harenberg J, Schmidt JA, Koppenhagen K, et al. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators. Thromb Haemost 2000;83:652-6.
    • (2000) Thromb Haemost , vol.83 , pp. 652-656
    • Harenberg, J.1    Schmidt, J.A.2    Koppenhagen, K.3
  • 5
    • 0024359217 scopus 로고
    • Comparative human pharmacology of low molecular weight heparins
    • Harenberg J, Stehle G, Augustin J, et al. Comparative human pharmacology of low molecular weight heparins. Semin Thromb Haemost 1989;15:414-23.
    • (1989) Semin Thromb Haemost , vol.15 , pp. 414-423
    • Harenberg, J.1    Stehle, G.2    Augustin, J.3
  • 6
    • 0036565886 scopus 로고    scopus 로고
    • How we diagnose and treat deep vein thrombosis
    • Hirsh J, Lee AY. How we diagnose and treat deep vein thrombosis. Blood 2002;99:3102-10.
    • (2002) Blood , vol.99 , pp. 3102-3110
    • Hirsh, J.1    Lee, A.Y.2
  • 7
    • 0035125405 scopus 로고    scopus 로고
    • Heparin and low-molecular heparin. Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy and safety
    • Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular heparin. Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy and safety. Chest 2001;119:64-94.
    • (2001) Chest , vol.119 , pp. 64-94
    • Hirsh, J.1    Warkentin, T.E.2    Shaughnessy, S.G.3
  • 8
    • 0028267616 scopus 로고
    • Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin - Results of a pilot study
    • Kirchmaier CM, Lindhoff-Last E, Rubesam D, et al. Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin - results of a pilot study, Thromb Res 1994;73:337-48.
    • (1994) Thromb Res , vol.73 , pp. 337-348
    • Kirchmaier, C.M.1    Lindhoff-Last, E.2    Rubesam, D.3
  • 9
    • 0031755859 scopus 로고    scopus 로고
    • Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis
    • Kirchmaier CM, Wolf H, Schäfer H, et al. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis, Int Angiol 1998;17:135-45.
    • (1998) Int Angiol , vol.17 , pp. 135-145
    • Kirchmaier, C.M.1    Wolf, H.2    Schäfer, H.3
  • 10
    • 0029969612 scopus 로고    scopus 로고
    • Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
    • The Tasman Study Group
    • Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996;334:682-7.
    • (1996) N Engl J Med , vol.334 , pp. 682-687
    • Koopman, M.M.W.1    Prandoni, P.2    Piovella, F.3
  • 11
    • 0027932867 scopus 로고
    • Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: A meta-analysis
    • Leizorovicz A, Simonneau G, Decousus H, et al. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ 1994;309:299-304.
    • (1994) BMJ , vol.309 , pp. 299-304
    • Leizorovicz, A.1    Simonneau, G.2    Decousus, H.3
  • 12
    • 0028939906 scopus 로고
    • Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis
    • Lensing AW, Prins M, Davidson BL, et al. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med 1995;155:601-7.
    • (1995) Arch Intern Med , vol.155 , pp. 601-607
    • Lensing, A.W.1    Prins, M.2    Davidson, B.L.3
  • 13
    • 0006590545 scopus 로고    scopus 로고
    • A comparison of low-molecular-weight heparin administered in the hospital for proximal deep-vein thrombosis
    • Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81.
    • (1996) N Engl J Med , vol.334 , pp. 677-681
    • Levine, M.1    Gent, M.2    Hirsh, J.3
  • 14
    • 0017687268 scopus 로고
    • Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy
    • Marder VJ, Soulen RL, Atichartakarn V, et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med 1977;89:1018-29.
    • (1977) J Lab Clin Med , vol.89 , pp. 1018-1029
    • Marder, V.J.1    Soulen, R.L.2    Atichartakarn, V.3
  • 15
    • 0035814834 scopus 로고    scopus 로고
    • Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease
    • Merli G, Spiro TE, Olsson CG, et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 2001;134:191-202.
    • (2001) Ann Intern Med , vol.134 , pp. 191-202
    • Merli, G.1    Spiro, T.E.2    Olsson, C.G.3
  • 16
    • 12244289623 scopus 로고    scopus 로고
    • Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study
    • Monreal M, Büller H, Lensing A, et al. Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study. Thromb Hemost 2002;88:938-42.
    • (2002) Thromb Hemost , vol.88 , pp. 938-942
    • Monreal, M.1    Büller, H.2    Lensing, A.3
  • 17
    • 0015289694 scopus 로고
    • Roentgen diagnosis of venous thrombosis in the leg
    • Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972;104:134-44.
    • (1972) Arch Surg , vol.104 , pp. 134-144
    • Rabinov, K.1    Paulin, S.2
  • 18
    • 12444319316 scopus 로고    scopus 로고
    • Fixed-dose body weight-independent subcutaneous low molecular weight heparin certoparin compared to adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis
    • Riess H, Koppenhagen K, Tolle AR, et al., for the TH-4 Study Group. Fixed-dose body weight-independent subcutaneous low molecular weight heparin certoparin compared to adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis. Thromb Haemost 2003; 89:252-59.
    • (2003) Thromb Haemost , vol.89 , pp. 252-259
    • Riess, H.1    Koppenhagen, K.2    Tolle, A.R.3
  • 19
    • 0029925784 scopus 로고    scopus 로고
    • Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
    • Siragusa S, Cosmi B, Piovella F, et al. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med 1996;100:269-77.
    • (1996) Am J Med , vol.100 , pp. 269-277
    • Siragusa, S.1    Cosmi, B.2    Piovella, F.3
  • 20
    • 0030858230 scopus 로고    scopus 로고
    • Low molecular weight heparins
    • Weitz JI. Low molecular weight heparins. N Engl J Med 1997;337:688-98.
    • (1997) N Engl J Med , vol.337 , pp. 688-698
    • Weitz, J.I.1
  • 21
    • 0028211342 scopus 로고
    • Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin
    • Young E, Wells P, Holloway S, et al. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin. Thromb Haemost 1994;71:300-4.
    • (1994) Thromb Haemost , vol.71 , pp. 300-304
    • Young, E.1    Wells, P.2    Holloway, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.